Loop Energy and Fraunhofer ISE Testing Demonstrates the Potential of Innovative eFlow™ Flow Field Design to Increase Hydrogen Production in Electrolyzers
6.3.2023 14:30:00 EET | Business Wire | Press release
Loop Energy ™ (TSX: LPEN), a designer and manufacturer of hydrogen fuel cell solutions, has completed third-party validation of the use of its patented eFlow™ technology in PEM electrolyzers. In partnership with Fraunhofer USA, testing was conducted by the German Fraunhofer Institute for Solar Energy Systems ISE, and has demonstrated a fuel cell architecture with trapezoid flow field design can enhance temperature uniformity. When incorporated into conventional PEM electrolysis cells, this bipolar plate architecture demonstrates it can increase hydrogen production. Loop Energy is now seeking industry partners to develop a full-scale electrolyzer prototype for commercial validation.
Results show that eFlow architecture creates a more stable and uniform operating environment in the PEM water electrolysis test cells compared to conventional flow fields with parallel channels, resulting in greater hydrogen production and improved efficiency. Testing also shows the enhanced uniform operating environment should have a beneficial impact on durability.
“Results from the validation process show that the new flow field technology has the potential to surpass typical levels of hydrogen production that we see in the industry today and supports green hydrogen production to become increasingly economically viable,” said Fraunhofer ISE Head of Department Chemical Energy Storage, Dr. Tom Smolinka. “The difference we have seen from current electrolyzer performance with conventional parallel flow field is that the adapted design appears to create more uniform temperature distribution could make it an enabling technology for some of the advanced materials needed to really increase the economics of electrolyzers and green hydrogen.”
Encouraged by the results, Loop Energy and Fraunhofer ISE are inviting expressions of interest from potential industry partners. Interested parties will partner with the two companies in designing and manufacturing an electrolyzer prototype to verify eFlow’s benefits for producing hydrogen on a commercial scale. All expressions of interest can be directed to Loop Energy Chief Commercial Officer, George Rubin.
“The completion of third-party validation is an important milestone for Loop Energy as we explore how eFlow can transform the hydrogen production sector,” said Loop Energy President & CEO, Ben Nyland. “We’re extremely pleased to partner with Fraunhofer ISE and draw on their long-lasting experience in cell and stack design for PEM water electrolysis. The results have been encouraging, and we’re excited to begin the search for strategic partners to support us as we innovate electrolyzer technology.”
Currently, Loop Energy’s proprietary eFlow technology is applied in its fuel cell products to offer unmatched levels of fuel efficiency. Its tapering channel design enables eFlow to provide improved uniform current density and increases gas velocity to deliver superior thermal and water management. With the new discovery that eFlow can benefit hydrogen production efficiency, it expands the patented technology’s potential use across the hydrogen energy vertical.
Global demand for hydrogen production is projected to grow by more than US$1 trillion by 20501. As a result, both new and existing hydrogen producers are searching for a competitive advantage to meet rising demand.
Ben Nyland will share details of this development at CERAWeek on March 6 and 7 alongside Thomas Schuelke, president of Fraunhofer USA, which also acts as project partner. In addition, Dr. Tom Smolinka and Loop Energy Chief Scientist, Dr. Sean Mackinnon will present the technical results at Hannover Messe on April 17. Requests for meetings at either event can be coordinated with Ethan Hugh.
Loop Energy’s management team will share more details on its end of year financial results call on March 30. Call details can be found on Loop Energy’s website.
About Fraunhofer ISE
The Fraunhofer-Gesellschaft, based in Germany, is the world's leading organization for application-oriented research. With its focus on key technologies of relevance to the future and on the exploitation of results in business and industry, it plays a central role in the innovation process. As a guide and stimulus for innovative developments and scientific excellence, it helps shape our society and our future. Founded in 1949, the organization currently operates 76 institutes and research facilities in Germany. More than 30,000 employees, most of them trained in the natural sciences or engineering, produce the annual research volume of 2.9 billion euros. Of this, 2.5 billion euros is spent on contract research. Further information: www.ise.fraunhofer.de/en
About Fraunhofer USA
Fraunhofer USA, Inc., a legally independent US affiliate founded by Fraunhofer-Gesellschaft, is an R&D organization working with industry, universities, and state and federal governments on contract R&D projects. Fraunhofer is in the high-tech problem-solving business and utilizes world class scientific and engineering expertise to engage in complex R&D projects across many different disciplines. Through Fraunhofer USA, U.S. clients can connect to the 79 research units throughout the U.S. and Germany with over 30,000 employees, predominantly scientists and engineers. www.fraunhofer.org
About Loop Energy Inc.
Loop Energy is a leading designer and manufacturer of hydrogen fuel cell systems targeted for the electrification of commercial vehicles, including light commercial vehicles, transit buses and medium and heavy-duty trucks. Loop Energy’s products feature the company’s proprietary eFlow™ technology in the fuel cell stack’s bipolar plates. eFlow is designed to enable commercial customers to achieve performance maximization and cost minimization. Loop Energy works with OEMs and major vehicle sub-system suppliers to enable the production of hydrogen fuel cell electric vehicles. For more information about how Loop Energy is driving towards a zero-emissions future, visit www.loopenergy.com.
Forward Looking Warning
This press release contains forward-looking information within the meaning of applicable securities legislation, which reflect management’s current expectations and projections regarding future events. Particularly, statements regarding the Company’s expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information, including without limitation, purchase orders, cost reduction, profitability and revenue targets; our future growth prospects and business outlook including without limitation the expected demand for our products, the allocation of resources and funds, the expected timeline for profitability, the planned growth of our customer base and the expected growth of our operations globally. Forward-looking information is based on a number of assumptions (including without limitation assumptions with respect the current and future performance of the Company’s products, growth in demand for the Company’s products, the Company’s ability to execute on its strategy, achieve its targets and progress existing and future customers through the Customer Adoption Cycle in a timely way, and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control and could cause actual results and events to vary materially from those that are disclosed, or implied, by such forward-looking information.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005095/en/
Contact information
Loop Energy Investor Inquiries:
Natalie Arseneau | Tel: +1 604.222.3400 Ext. 418 | investors@loopenergy.com
Loop Energy Business Inquiries:
George Rubin | Tel: +1.604.828.8185 | grubin@loopenergy.com
Loop Energy Media Inquiries:
Ethan Hugh | Tel: +1 604.306.4277| ethan.hugh@loopenergy.com
Lucas Schmidt | Tel: +1.778.791.8756 | lucas.schmidt@loopenergy.com
Fraunhofer ISE Inquiries:
Dr. Tom Smolinka | Tel: +49.761.4588.5212 | tom.smolinka@ise.fraunhofer.de
Diana Bribach | Tel: +49.761.4588.2804 | diana.bribach@ise.fraunhofer.de
Fraunhofer USA Inquiries:
Elliott Sprehe | Tel: +734.927.3984 | esprehe@fraunhofer.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 04:00:00 EEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 11:01:00 EEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
